U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H25NO2.ClH
Molecular Weight 347.879
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FOMOCAINE HYDROCHLORIDE

SMILES

Cl.C(CN1CCOCC1)CC2=CC=C(COC3=CC=CC=C3)C=C2

InChI

InChIKey=HWDXMCUKRADNLV-UHFFFAOYSA-N
InChI=1S/C20H25NO2.ClH/c1-2-6-20(7-3-1)23-17-19-10-8-18(9-11-19)5-4-12-21-13-15-22-16-14-21;/h1-3,6-11H,4-5,12-17H2;1H

HIDE SMILES / InChI

Molecular Formula C20H25NO2
Molecular Weight 311.418
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Fomocaine is a local anesthetic used in the gel formulations for the relief of pain associated with burns and wounds. Fomocaine blocks both sodium and calcium voltage-gated ion cahnnel currents.

Originator

Sources: www.drugfuture.com/chemdata/fomocaine.html

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
100.0 µM [Ki]
Conditions
PubMed

PubMed

TitleDatePubMed
Local anaesthetic effectivity and toxicity of fomocaine, five N-free fomocaine metabolites and two chiralic fomocaine derivatives in rats compared with procaine.
2001
[Synthesis and pharmacologic action of chiral fomocaine ((4-[2-methyl-3-(morpholin-4-yl)propyl)benzyl)-phenyl-ether and (4-(1-methyl-3-(morpholin-4-yl)propyl]benzyl)-phenyl-ether). 13. Synthesis of new compounds with local anesthetic action].
2001 Aug
[[Physical chemical, pharmacological and toxicologic properties of fomocaine metabolites] ].
2001 Jan
Local anaesthetic effects and toxicity of seven new diethanolamine and morpholine derivatives of fomocaine. Testing in rats compared with procaine and tetracaine.
2003
Effects and toxicity of new fomocaine derivatives and of 2-hydroxypropyl-beta-cyclodextrin inclusion compounds in rats.
2004
In vitro interactions with the Cytochrome P450 system, toxicity, and local anaesthetic effects of Fomocaine Alkylmorpholine derivatives in rats.
2006
A synopsis on different homologous series of fomocaine derivatives. In vitro interactions with the cytochrome P450 system, toxicity, and local anaesthetic effects in rats--Part III.
2007
A synopsis on different homologous series of fomocaine derivatives. In vitro interactions with the cytochrome P450 system, toxicity, and local anaesthetic effects in rats--part II.
2007
Blockade of TTX-resistant and TTX-sensitive Na+ currents in cultured dorsal root ganglion neurons by fomocaine and the fomocaine derivative Oe 9000.
2010 Oct 28
Patents

Patents

Sample Use Guides

Unknown
Route of Administration: Transdermal
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:33:36 UTC 2023
Edited
by admin
on Sat Dec 16 08:33:36 UTC 2023
Record UNII
96285SEX30
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FOMOCAINE HYDROCHLORIDE
WHO-DD  
Common Name English
MORPHOLINE, 4-(3-(4-(PHENOXYMETHYL)PHENYL)PROPYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
MORPHOLINE, 4-(3-(4-(PHENOXYMETHYL)PHENYL)PROPYL)-, HYDROCHLORIDE
Systematic Name English
Fomocaine hydrochloride [WHO-DD]
Common Name English
Code System Code Type Description
PUBCHEM
171527
Created by admin on Sat Dec 16 08:33:36 UTC 2023 , Edited by admin on Sat Dec 16 08:33:36 UTC 2023
PRIMARY
EPA CompTox
DTXSID80205137
Created by admin on Sat Dec 16 08:33:36 UTC 2023 , Edited by admin on Sat Dec 16 08:33:36 UTC 2023
PRIMARY
CAS
56583-43-8
Created by admin on Sat Dec 16 08:33:36 UTC 2023 , Edited by admin on Sat Dec 16 08:33:36 UTC 2023
PRIMARY
FDA UNII
96285SEX30
Created by admin on Sat Dec 16 08:33:36 UTC 2023 , Edited by admin on Sat Dec 16 08:33:36 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY